CIK 0001863127 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831476348
- Phone
- (619) 728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 72 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-13 | Harris Todd President and CEO | Grant or award | +1,350 | $6.58 | $9K | 1,505,927 |
| 2024-09-13 | Fuhrman Alan Chief Financial Officer | Grant or award | +954 | $12.48 | $12K | 3,349 |
| 2024-09-09 | Warner Douglas J Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +260,000 | 260,000 | ||
| 2024-08-14 | Bensen Daniel Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2024-08-14 | Harris Todd President and CEO | Grant or award · Stock Option (Right to Buy) | +390,000 | 390,000 | ||
| 2024-08-14 | Fuhrman Alan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2024-06-13 | KAPLAN GILLA Director | Option exercise | +61,392 | $0.61 | $37K | 89,623 |
| 2024-06-13 | KAPLAN GILLA Director | Option exercise · Stock Option (Right to Buy) | −61,392 | 0 | ||
| 2024-06-10 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −3,502 | $20.00 | $70K | 427,981 |
| 2024-06-07 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −200 | $20.00 | $4K | 431,483 |
| 2024-05-29 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (right to buy) | +18,600 | 18,600 | ||
| 2024-05-29 | Subramony Siddarth Director | Grant or award · Stock Option (Right to Buy) | +18,600 | 18,600 | ||
| 2024-05-29 | MORE ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +18,600 | 18,600 | ||
| 2024-05-29 | Simson Jake Director | Grant or award · Stock Option (Right to Buy) | +18,600 | 18,600 | ||
| 2024-05-29 | Verjee Rehan Director | Grant or award · Stock Option (Right to Buy) | +18,600 | 18,600 | ||
| 2024-05-29 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +18,600 | 18,600 | ||
| 2024-05-29 | Kjellson Nina S Director | Grant or award · Stock Option (Right to Buy) | +18,600 | 18,600 | ||
| 2024-05-07 | Moran Susan Director | Grant or award · Common Stock (Right to Buy) | +37,200 | 37,200 | ||
| 2024-05-07 | Rothenberg Stephen Michael Director | Grant or award · Common Stock (Right to Buy) | +37,200 | 37,200 | ||
| 2024-03-15 | Fuhrman Alan Chief Financial Officer | Grant or award | +932 | $12.48 | $12K | 2,395 |
Page 7 of 9 · 170 trades